T issue blood flow is precisely matched with energetic demand through an intricate network of resistance arteries responding to hemodynamic and chemical stimuli. [1] [2] [3] Vasoactive stimuli typically augment tone via defined G-protein coupled receptors and downstream transduction pathways that favor myosin light chain phosphorylation. 4 ,5 A key step in this transduction process is the induction of depolarization and the subsequent influx of Ca 2+ via voltage-gated Ca 2+ channels. 6, 7 To tune this electrical response and to prevent excessive constriction, nature has encoded the arterial wall with resident K + conductances to provide negative feedback. These include (1) voltage-dependent K + (K V ) channels, comprised of pore-forming subunits from the K V 1, 2, and 7 subfamilies [8] [9] [10] ; and (2) large-conductance Ca 2+ -activated K + (BK Ca ) channels. 11, 12 BK Ca channels are the only K + conductance in vascular smooth muscle gated by both voltage and Ca 2+ . Structurally, they are comprised of 4 pore-forming α subunits, along with auxiliary β and γ subunits which modulate Ca 2+ sensitivity, channel kinetics and, trafficking. 13, 14 In key organs, the opening of vascular BK Ca is manifested in the form of spontaneous transient outward currents (STOCs), discrete electrical events tied to Ca 2+ spark generation. 15 Ca 2+ sparks reflect the transient activation of RyR (ryanodine receptors), and a single spark is known to increase [Ca 2+ ] in the vicinity of BK Ca to 30 µM. 11, 12, 15 The opening of RyR2 is in turn Ca 2+ -dependent and initiated by extracellular Ca 2+ influx through 3 membrane conductances. 16, 17 One of particular note is Ca V 3.2 (T-type Ca 2+ channel encoded by the α-3.2 subunit), a T-type Ca 2+ channel that directly triggers the cytosolic gating of RyR2 because of the close proximity of the 2 proteins. 18, 19 How this close structural arrangement is attained remains unclear, although past structural work has implied that lipid rafts may be key. 18 Of note are caveolae, flask-like structures historically known to localize membrane proteins with their intracellular targets in restricted microdomains. [18] [19] [20] [21] [22] This study examined whether caveolae position Ca V 
Materials and Methods
The authors declare that all supporting data are available within the article and in the online-only Data Supplement. 
Animal Procedures

Isolation of Mesenteric Arterial Smooth Muscle Cells
To liberate smooth muscle cells from intact mesenteric arteries, vessel segments were placed in an isolation media (37°C, 10 minutes) containing (in mM) 60 NaCl, 80 Na-glutamate, 5 KCl, 2 MgCl 2 , 10 glucose, and 10 HEPES with 1 mg/mL BSA (pH 7.4). Arteries were then exposed to a 2-step digestion process that began with 14-minute incubation (37°C) in media containing 0.5 mg/mL papain and 1.5 mg/mL dithioerythritol, followed by 10-minute incubation in media containing 100 μM Ca 2+ , 0.7 mg/mL type F collagenase, and 0.4 mg/mL type H collagenase. After incubation, tissues were washed repeatedly with ice-cold isolation media and triturated with a fire-polished pipette. Liberated cells were stored on ice for use on the same day.
Electrophysiological Recordings
Whole-cell currents were measured in isolated smooth muscle cells using an Axopatch 200B patch-clamp amplifier (Molecular Devices, Sunnyvale, CA); data were filtered at 1 kHz, digitized at 5 kHz, and stored on a computer for offline analysis with Clampfit 10.3 software (Molecular Devices, Sunnyvale, CA). Whole-cell capacitance averaged 14 to 18 pF and was measured with the cancellation circuitry on the patch-clamp amplifier. Access resistance (8 to 10 mol/LΩ) was monitored every 60 s, and cells that changed >2 mol/LΩ during the experiment were excluded. To minimize offset potential (<2 mV), a 1 mol/L NaCl-agar salt bridge between the reference electrode and the bath solution was used. All experiments were performed at room temperature (≈22°C).
Conventional whole-cell patch-clamp electrophysiology was used to measure voltage-gated Ca 2+ currents in mesenteric smooth muscle cells. In brief, recording electrodes (5-8 mol/LΩ) were fabricated from borosilicate microcapillary tubes (Sutter Instruments, Novato, CA) using a micropipette puller (Narishige PP-830, Tokyo, Japan). Glass electrodes were backfilled with pipette solution (in mM) 135 CsCl, 5 Mg-ATP, 10 HEPES, and 10 EGTA (pH 7.2) while cells were placed in a bathing solution (in mM) 110 NaCl, 1 CsCl, 10 BaCl 2 , 1.2 MgCl 2 , 10 glucose, and 10 HEPES pH 7.4. Pipettes were gently lowered onto a smooth muscle cell and back pressure applied to rupture the membrane to garner intracellular access. From a holding potential of −60 mV, steady-state current was assessed by subjecting smooth muscle cells to a prepulse (−90 mV, 200 ms) and then to 10-voltage steps (300 ms each) ranging between −50 and 40 mV (10-mV increments). I-V relationships were plotted as current densities (pA/pF) at each voltage step. Voltage-dependence of steady-state inactivation was assessed by a step protocol: (1) prepulse to −90 mV (300 ms); (2) stepping from −70 to +20 mV (10-mV intervals; 1.5 s each); (3) hyperpolarizing back to −90 mV (10 ms); and (4) stepping to a test voltage of 10 mV (200 ms). Whole-cell currents elicited by the test voltage were normalized to maximal current and plotted versus the voltage step. The voltage-dependence of activation was evaluated by monitoring isochronal tail currents. In detail, cells were subjected to a prepulse (−90 mV; 300 ms), voltage steps (−80 to 40 mV; 10-mV intervals, 50 ms) and then a final hyperpolarizing test pulse (−90 mV; 200 ms) to evoke tail currents. Normalized tail currents (%I/I max ) were plotted versus the voltage step. Delineation of vascular voltage-gated Ca 2+ channels was performed as previously described. 23, 24 In brief, 200 nmol/L nifedipine is first added to block Ca V 1.2 (L-type Ca 2+ channel encoded by the α-1.2 subunit) channels followed by 50 µmol/L Ni 2+ to selectively block Ca V 3.2 channel without affecting Ca V 3.1 (T-type Ca 2+ channel encoded by the α-3.1 subunit) 19, 24 . STOC production was assessed in mesenteric smooth muscle cells using perforated patch-clamp electrophysiology. 18, 19 Cells were bathed in solution containing (in mM) 134 NaCl, 4 KCl, 2 MgCl 2 , 2 CaCl 2 , 10 glucose, and 10 HEPES (pH 7.4); the pipette solution was comprised of (in mM) 110 K aspartate, 30 KCl, 10 NaCl, 2 MgCl 2 , 10 HEPES, 0.05 EGTA (pH 7.2), and 250 µg/mL amphotericin B. STOCs were recorded in mesenteric smooth muscle cells held at −40 mV. Threshold for STOC detection was ≈3× BK Ca single-channel conductance.
Vessel Myography and V M Measurements
Arterial segments were mounted in a customized arteriograph and superfused with warm (37°C) physiological salt solution (pH 7.4; 21% O 2 , 5% CO 2 , balance N 2 ) containing (in mM) 119 NaCl, 4.7 KCl, 20 NaHCO 3 , 1.1 KH 2 PO 4 , 1.2 MgSO 4 , 1.6 CaCl 2 , and 10 glucose. 19 To limit the influence of the endothelium, air bubbles were passed through the vessel lumen (1 minute); successful endothelial removal was confirmed by the loss of bradykinin-induced dilation. Arteries were equilibrated at 15 mm Hg, and contractile responsiveness was assessed by brief application of 60 mmol/L KCl. After equilibration, intravascular pressure was elevated from 20 physiological salt solution) or treated conditions and D 0 is external diameter in Ca 2+ -free physiological salt solution. Arterial V M was assessed by gently inserting a glass microelectrode backfilled with 1 mol/L KCl (tip resistance ≈120-150 mol/LΩ) into the vessel wall (intravascular pressure, 60 mm Hg). Measurements were made under control conditions and in the presence of Ni 2+ and paxilline. Criteria for successful impalement were (1) sharp negative V M deflection on electrode insertion; (2) stable V M reading for a minimum of 1 minute after entry; and (3) sharp return to baseline on electrode removal.
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Quantitative Polymerase Chain Reaction
This study isolated total RNA from C57Bl/6 and caveolin 1 −/− mesenteric smooth muscle cells using the RNeasy plus micro kit (Qiagen) following the manufacturer's instructions. Reverse transcription was performed with 20 ng per sample of total RNA using the Quantinova reverse transcription kit (Qiagen). A reaction mixture devoid of the reverse transcriptase was used as a negative control group. Intronspanning primer sequences along with the PCRBIO SyGreen mastermix (PCR Biosystems) were used for real-time polymerase chain reaction. Mouse β-actin was used as the reference gene. Control reactions and those containing cDNA from isolated smooth muscle cells were performed with 1 ng of template. The running protocol extended to 45 cycles consisting of 95°C for 5 s, 55°C for 10 s, and 72°C for 10 s using an Eppendorf Realplex 4 Mastercycler. Dissociation curve analysis was used to check polymerase chain reaction specificity, and assay validation was confirmed by testing serial dilutions of pooled template cDNAs suggesting a linear dynamic range of 50 to 0.05 ng template and yielded percent efficiencies ranging from 85% to 95%. No-template controls did not yield detectable fluorescence. The relative expression software tool version 2.0.13.2 was used to determine mRNA expression levels in mesenteric smooth muscle cells; caveolin 1 −/− data were expressed relative to C57BL/6. Primer sequences used are as follows: Ca V 1.2; ATTCGACGTGAAGGCACTG and GAGTTCAGGACCACCTGGAG, Ca V 3.1; TCCTGGTCAATACCC TCAGC and GAGGCTGGTGAAGACGATGT, BK Ca α; TCTCAGC ATTGGTGCCCTCGTAAT and GTAGAGGAGGAAGAACACGTT GAA; RyR2; CTGAGCTGGCATTCAAGGAC and AGCCTTCTT GTAAGCCACAG, ACTB (β-actin); ACTGTC GAGTCGCGTCCA and GCAGCGATATCGTCATCCAT; Ca V 3.2; CAGCCATCCTCG TCAATACTC and CTTCAGTAGCATCTCCAAGGC.
Ca
2+ Sparks Measurement
Ca 2+ sparks were measured in murine mesenteric smooth muscle cells loaded with the Ca 2+ sensitive dye Fluo-4 am and using a Zeiss LSM 710 NLO laser scanning confocal imaging workstation on an inverted microscope platform (Zeiss Axio Observer Z1). 19 Fluo-4 am dissolved in dimethyl sulfoxide (1 mmol/L stock) was added to an arterial suspension for 1 to 1.5 hours at room temperature (working concentration, 10 μM) along with 0.1% pluronic F127. Arterial segments were then washed for 30 minutes to allow dye esterification and then cut into linear strips. The arterial segments were pinned to Sylgard blocks and placed in an open bath imaging chamber mounted on the confocal imaging stage. KCl (25 mmol/L) was used to augment Ca 2+ spark generation and set smooth muscle V M near the K + equilibrium potential of −43.8 mV, a voltage that coincides with peak T-window current. 24, 25 Cells were illuminated at 488 nm with a krypton-argon laser, and the emitted light was collected using a photomultiplier tube. Line scans were imaged at 529 fps with the emission signal recorded at 493 to 622 nm. The acquisition period for Ca 2+ spark recordings was 18.9 s. The resultant pixel size ranged from 0.021 to 0.1 μm per pixel. To ensure that sparks within the cell were imaged, the pinhole was adjusted to provide an imaging depth of 2.5 μm. This depth is roughly equivalent to the width of 50% of the cell based on morphological examination of live preparations. Line scans were analyzed using Sparklab 4.3.2 to characterize the percentage of scans with Ca 2+ sparks and the Ca 2+ sparks frequency. The threshold for spark detection was 3.2× the SD of the background noise above the mean background level. Before analysis, the background fluorescence was subtracted from each image assuming homogeneous background levels in each cell.
Immunostaining and Proximity Ligation Assay
The Duolink in situ proximity ligation assay (PLA) detection kit was used on freshly isolated smooth muscle cells. In brief, cells were fixed in PBS containing 4% paraformaldehyde (15 minutes) and then incubated with PBS containing 0.2% tween (15 minutes) for permeabilization. Cells were washed with PBS, blocked by Duolink blocking solution (1 hour), and incubated overnight with primary antibodies (mouse anti-Ca V 3.2, rabbit anti-caveolin 1, or rabbit anti-RyR2) in Duolink antibody diluent solution (4°C). One primary antibody was removed for control experiments. Cells were then washed with Duolink washing solution and labeled with Duolink PLA PLUS and MINUS probes for 1 hour (37°C). The secondary antibodies of the PLA PLUS and MINUS probes are attached to synthetic oligonucleotides that hybridize if present in close proximity (<40 nm). The hybridized oligonucleotides are then ligated and subjected to amplification. The amplified products extending from the oligonucleotide arm of the PLA probe were detected using far-red fluorescent fluorophore-tagged, complementary oligonucleotide sequences and a Leica TCS SP8 confocal microscope.
For immunolabeling, freshly isolated smooth muscle cells were fixed in PBS containing 4% paraformaldehyde (15 minutes) and then incubated with PBS containing 0.2% tween (15 minutes) for permeabilization. Cells were washed with PBS blocked by Duolink blocking solution (1 hour) and incubated overnight with primary antibodies (rabbit anti-Ca V 3.2 or rabbit anti-caveolin 1) in Duolink antibody diluent solution at 4°C. Control experiments used no primary antibody or 1 primary antibody. Cells were then washed with Duolink washing solution and incubated with working Duolink diluent solutions containing secondary antibodies (1 hour, 22°C). After washes with Duolink solution, cells were mounted on gel-coated slides, and coverslips were sealed with nail polish. All reactions involved the use of fluorophore-conjugated secondary antibodies (1:1000 dilution): Alexa Fluor 488-donkey anti-rabbit IgG. Immunolabelling was assessed using Leica TCS SP8 confocal microscope.
Statistical Analysis
Data are expressed as means±SE, and n indicates the number of cells, arteries, or animals. Brown-Forsythe and Shapiro-Wilk tests ascertained equality of group variances and normal distribution of data, respectively. Paired/unpaired t tests or 1-way ANOVA with Bonferroni correction were performed to compare the effects of a given condition/treatment on whole-cell current, arterial diameter, or V M . P values ≤0.05 were considered statistically significant.
Solutions and Chemicals
Primary antibodies against Ca V 3.2, caveolin 1, and RyR2 were purchased from Novus Biologicals, Abcam, and Alomone Laboratories. Alexa Fluor 488-donkey anti-rabbit IgG was acquired from Invitrogen. Duolink PLA detection kits and all other chemicals were obtained from Sigma-Aldrich unless stated otherwise. For more details, please check the Major Resources Table in the online-only Data Supplement.
Results
The first step in establishing a relationship between Ca V 3.2 and caveolae is to localize the channel with a key caveolae protein (ie, caveolin 1). 22 In this regard, we performed immunohistochemistry and, as Figure 1 illustrates, both proteins are expressed in mesenteric smooth muscle cells. Caveolin 1 labeling was particularly prominent, whereas Ca V 3.2 staining was more discrete in the plasma membrane. PLA was next used to establish protein colocalization and consistent with Ca V 3.2 and caveolin 1 residing within 40 nm of one another, punctate red fluorescent product (≈7-13 puncta per cell) was observed. Control experiments, where 1 or both primary antibodies were removed, had markedly decreased punctate fluorescent product.
To ascertain the importance of the Ca V 3.2-caveolae relationship to feedback control, electrophysiological experiments were performed in the presence of methyl-β-cyclodextrin (MβCD, 10 mmol/L) to destabilize lipid rafts. Cells treated with this cholesterol depleting agent displayed a robust Ba Figure 2D ). In C57BL/6 cells, the MβCD-induced reduction in Ca V 3.2 activity coincided with reduced STOC production ( Figure 3A) ; a similar decrease was absent in Ca V 3.2 −/− smooth muscle cells ( Figure 3A) . Additional controls confirmed that Ni 2+ failed to alter STOC production in C57BL/6 cells pretreated with MβCD ( Figure 3B ). Of note, MβCD attenuated myogenic constriction by ≈80%, limiting further functional experimentation ( Figure I in the online-only Data Supplement).
Genetic deletion of caveolin 1 disrupts the formation and maintenance of caveolae. 26 Using this model, this study found that 1 consequence of this genetic modification was the mistargeting of Ca V 3.2. In detail, Figure 4A highlights that the punctate red fluorescence signal consistent with a close association between Ca V 3.2 and RyR2 was robust in C57BL/6 smooth muscle cells (≈6-10 puncta per cell) while absent from caveolin 1 −/− tissue. Control experiments subsequently confirmed that PLA product was also absent from cells where 1 primary antibody had been removed from the assay. Intriguingly, the likely loss of channel localization -sensitive current, with leftward shifted activation/inactivation kinetics reminiscent of T-type channels ( Figure 4B-4D) . The nifedipine-sensitive current, indicative of Ca V 1.2 activity, was similarly robust among the 2 groups of cells, as was the residual nifedipine/Ni 2+ -insensitive component, attributable to Ca V 3.1. Quantitative polymerase chain reaction analysis also confirmed that mRNA expression of key channels subunits was notably similar among C57BL/6 and caveolin 1 −/− cells ( Figure 4E ). Without the expression of caveolin 1, Ca V 3.2 could no longer trigger its downstream target, RyR2. In detail, Ni 2+ failed to diminish Ca 2+ spark production (ie, % firing or frequency) in caveolin 1 −/− mesenteric arteries, an observation that contrasts C57BL/6 arteries ( Figure 5A and 5B). Reduced coupling between Ca V 3.2 and RyR2 additionally lowered basal Ca 2+ spark production in caveolin 1 −/− arteries (27% and 0.002±0.0005 sparks/µm) relative to C57BL/6 (59% and 0.01±0.0027 sparks/µm). Predictably, Ni 2+ -sensitive STOC production was absent in caveolin 1 −/− cells ( Figure 5C ), whereas this Ca V 3.2 blocker induced a ≈60% suppression in C57BL/6 cells ( Figure 3C ). STOC amplitude was constant among the 2 groups, and all recordings were performed at −40 mV, a voltage comfortably within the physiological range. 24, 25 Functional experiments subsequently assessed the impact of caveolin 1 deletion on the ability of Ca V 3.2 to regulate arterial tone. In C57BL/6 mesenteric arteries, Ni 2+ blockade increased tone from 27% to 34% (Figure 6A ), whereas a similar constriction was absent in caveolin 1 −/− vessels. Of note, baseline diameter and maximal dilation of caveolin 1 −/− arteries (180±10.45 and 210±10.56) were modestly, yet significantly larger than C57BL/6 vessels (162±8.9 and 194±9.78). Both groups of vessel displayed a comparable constrictor response to 60 mmol/L KCl ( Figure 6C ). Although Ni 2+ had little effect in caveolin 1 −/− arteries, paxilline (1 µM) induced a notable constriction, confirming that the BK Ca channel was functional in knockout tissues ( Figure 6B) . In C57BL/6 arteries, paxilline (1 µmol/L) application on top of Ni 2+ , had a marginal vasomotor effect, a finding indicative of Ca V 3.2 and BK Ca being sequentially ordered in a common signaling pathway ( Figure 6A) . Consistent with the vasomotor observations, V M recordings revealed that Ni 2+ depolarized arteries from C57BL/6 but not caveolin 1 −/− mice ( Figure 6D ). Caveolin 1 −/− arteries did depolarize to BK Ca blockade by paxilline ( Figure 6D ).
Discussion
This study examined the localization of Ca V 3.2 and whether caveolae are necessary to couple this T-type channel to Ca 2+ spark and STOC production in vascular smooth muscle. PLA first confirmed a close association between Ca V 3.2 and caveolin 1, the dominant scaffolding protein in caveolae. Next, chemical disruption of caveolae attenuated Ca V 3.2 activity, an event which hindered the triggering of STOCs. Genetic ablation of caveolae (caveolin 1 −/− ) also attenuated STOC production, albeit without suppressing Ca V 3.2 current. The latter finding suggests that Ca V 3.2 has mislocalized in the plasma membrane, a view which aligns with the loss of Ni 2+ -sensitive Ca 2+ spark generation and the failure of PLA to place this T-type channel near RyR2. The functional consequence of mislocalization was that Ca V 3.2 activity could no longer impact arterial V M or myogenic tone in caveolin 1 −/− mice. We conclude that caveolae are essential in placing Ca V 3.2 sufficiently close to RyR2 so that the negative feedback can be generated and arterial tone development optimized.
Background
The magnitude and distribution of tissue blood flow is dynamically controlled by resistance arteries that respond to chemical and mechanical stimuli.
1-3 Working through G-protein coupled receptors and signaling pathways, the principal means by which stimuli augment tone is by depolarizing smooth muscle and elevating cytosolic [Ca 2+ ] through the activation of voltage-gated Ca 2+ channels. 6 Irrespective of the stimulus, it is evident that the initial depolarizing step is tightly regulated and countered by resident voltage-dependent K + conductances Figure 4 . Genetic deletion of caveolin 1 mislocalizes T-type Ca 2+ channel encoded by the α-3.2 subunit (Ca V 3.2) without impairing intrinsic channel activity. A, Representative proximity ligation assay images reveal the close proximity of Ca V 3.2 with RyR2 (ryanodine receptor 2; red fluorescent product) in C57BL/6 but not caveolin 1 −/− smooth muscle cells; nuclei were labeled with DAPI (4',6-diamidino-2-phenylindole; blue). Controls were performed with 1 or both primary antibodies removed. These experiments were performed on cells from 5 different animals; photomicrographs are representative 10 to 20 smooth muscle cells per animal. B and C, Ca V currents were assessed by whole-cell patch clamp by subjecting cells (holding potential, −60 mV) to a prepulse (−90 mV, 200 ms) and then to a 10-step protocol ranging between −50 and 40 mV (300 ms each). Representative traces averaged current-voltage (I-V), and peak current (I max ) plots of whole-cell Ba within the arterial wall. 27 Of particular note is BK Ca , a channel whose activation is coupled to depolarization and a micromolar [Ca 2+ ] rise. To achieve local [Ca 2+ ] 10 to 30× greater than bulk cytosol, the sarcoplasmic reticulum (SR) forms a restricted microdomain with the plasma membrane into which Ca 2+ is transiently released from RyR2. 12, 28 The gating of RyR2 is in turn dependent on extracellular Ca 2+ influx through 3 membrane conductances (Ca V 1.2, Ca V 3.2, and Na + /Ca 2+ exchanger) that either trigger the cytosolic gate or impact SR refilling rate. 16 Ca 2+ spark production at physiological voltages is strongly but not exclusively tied to Ca V 3.2, a T-type channel closely linked with RyR2, triggering its cytosolic gate. 18, 19 Although it is uncertain how this close arrangement is maintained to support vascular function, one can infer from past studies a role for caveolae. 22 If indeed crucial, then disruption should impact Cav3.2's association with proteins in caveolae and the SR and secondarily compromise BK Ca -mediated feedback from the cell to the tissue level.
Structural Localization of Ca V 3.2
Caveolae are specialized lipid rafts (60-80 nm width) characterized as invaginations of the plasma membrane. [29] [30] [31] These flask-like structures are rich in cholesterol and partition membranes into microdomains to regulate transduction processes, including Ca 2+ dynamics. 30, 31 The formation and maintenance of caveolae formation are intimately tied to 2 groups of scaffolding proteins (caveolins and cavins), with caveolin 1 being particularly prominent in vascular tissues. 20, 26, 32 Findings in Figure 1 confirmed that caveolin 1 was robustly expressed in mesenteric smooth muscle and that Ca V 3.2 was also present, although its localization pattern was more discrete. PLA, a technology that extends traditional immunoassays, also confirmed that Ca V 3.2 lies within 40 nm of caveolin 1. This close association implies that Ca V 3.2 is not only present in caveolae, consistent with immunogold work from cerebral arteries, but also that the 2 proteins likely interact. 18, 33 Further work is required to determine the precise nature of this interaction and whether the Ca V 3.2-caveolae relationship is truly conserved across vascular beds and species.
Cholesterol Depletion
As Ca V 3.2 localizes to caveolae, it is logical to argue that lipid raft disruption would compromise this channel's ability to target its downstream effector, BK Ca. To test this assertion, smooth muscle cells were treated with MβCD-depleting membranes of cholesterol, a lipid necessary for caveolin oligomerization. 21, 34 In the presence of MβCD, Ca V 3.2 activity decreased in mesenteric smooth muscle cells, as assessed with a carefully crafted pharmacological approach (Figure 2) . 19, 24 That approach entailed bathing cells in 10 mmol/L Ba 2+ and monitoring the resulting whole-cell current as 200 nmol/L nifedipine is first added to eliminate Ca V 1.2, then 50 µM Ni 2+ to selectively block Ca V 3.2 and not Ca V 3.1. Ca V 3.2 suppression coincided with a diminishment of STOCs, the transient opening of BK Ca initiated by Ca 2+ sparks, SR driven events (Figure 3) . 12 Further evidential lines support a linkage, one being that cholesterol depletion failed to attenuate T-type current and STOC production in Ca V 3.2 −/− mice (Figures 2 and  3) . Secondarily, Ca V 3.2 blockade by Ni 2+ failed to alter STOCs in cells preincubated with MβCD (Figure 3) . Although cholesterol depletion has been previously reported to decrease Ca 2+ spark production, this study links this attenuation to diminished Ca V 3.2 activity. 20, 21 In considering these findings, interpretational caution is warranted as the effects of MβCD could extend beyond caveolae to membrane phospholipids and intracellular structures. 34 Thus, finding an alternative approach to manipulate Ca V 3.2, particularly one that doesn't diminish activity, would be valuable in advancing the current line of reasoning.
Disrupted Signaling in Caveolin 1 −/− Mice
Genetic deletion of caveolin 1 impinges on caveolae formation, a change likely to impact either the activity or localization of Ca V 3.2. 20, 26 PLA and patch recordings in Figure 4 build a compelling case, that it is the latter and not the former. in C57BL/6 tissues ( Figure 5) -sensitive STOC production was also lost in caveolin 1 −/− mice. The functional consequence of these cellular changes was that BK Ca -mediated feedback, in particular that portion tied to Ca V 3.2, was lost in mesenteric arteries. This was carefully noted in Figure 6 , where Ca V 3.2 blockade induced constriction in wild-type but not in caveolin 1 −/− arteries pressurized to 60 mm Hg where smooth muscle V M aligns with the channel's peak window current. 6, 25 Arterial V M measures supported the vasomotor observations, with Ni 2+ inducing depolarization in C57BL/6 but not caveolin 1 −/− arteries. This lack of effect did not result from direct BK Ca silencing in caveolin 1 −/− arteries, as paxilline was able to induce marked constriction. Although all arteries responded robustly to 60 mmol/L KCl, this study did note that myogenic tone was modestly weaker in caveolin 1 −/− mice. This intriguing effect wasn't attributable to disrupted BK Ca feedback or altered nitric oxide production, as vessels were denuded of endothelial cells. 20, 26 It could reflect a partial disruption of Rho A translocation, an event key to the inhibition of myosin light chain phosphorylase and the maintenance of tone development.
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Summary
In summary, findings reveal that Ca V 3.2 reside in caveolae in close apposition to RyR2. This intimate relationship enables Ca 2+ influx through Ca V 3.2 channels to directly trigger the cytosolic gate of RyR2 and initiate Ca 2+ sparks, key transduction events involved in STOC production. This rise in BK Ca activity provides a form of negative feedback that moderates the ability of intravascular pressure to depolarize and constrict resistance arteries. In considering these findings, it is important to note that 3 distinct membrane conductances work collectively to set the voltage range and magnitude of the BK Ca -mediated response. 16, 35, 36, 38 Ablating 1 conductance will not, therefore, eliminate feedback control but will instead shift its operational range and performance. Thus, the mistargeting of Ca V 3.2 channels with their negatively shifted voltage profile will disproportionally reduce feedback at more hyperpolarized voltages. 25 Such an uncompensated loss of BK Ca -mediated feedback would foster a rise in basal tone akin to arterial observations in hypertensive and diabetic rodents. 
